Evidence map›Paper›PMID 33489449›Full record

ArticleAmerican journal of blood research2020

TaibUVID nutritional supplements help rapid cure of COVID-19 infection and rapid reversion to negative nasopharyngeal swab PCR: for better public prophylaxis and treatment of COVID-19 pandemic.

Salah Mohamed El Sayed, Moutasem Salih Aboonq, Yasmeen Talal Aljehani, Mohammad Ahmad Hassan, Rabab M Abou El-Magd, Abdelrahman I Abdelrahman, Rehab El-Tahlawi, Manal Mohamed Helmy Nabo, Reda S Yousef, Ahmed Alamir Mahmoud and 10 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in American journal of blood research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 11 institutions in 4 countries.

Salah Mohamed El SayedDepartment of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University Al-Madinah Al-Munawwarah, Saudi Arabia.
Moutasem Salih AboonqDepartment of Medical Physiology, Taibah Faculty of Medicine, Taibah University Al-Madinah Al-Munawwarah, Saudi Arabia.
Yasmeen Talal AljehaniDirector of The Research and Studies Department of Health Affairs in Al-Madinah Region, Consultant Family Medicine and Trainer in Family Medicine Program for Postgraduate Studies Al-Madinah Al-Munawwarah, Saudi Arabia.
Mohammad Ahmad HassanDepartment of Pediatrics, Sohag Faculty of Medicine, Sohag Univerity Egypt.
Rabab M Abou El-MagdDepartment of Psychiatry, Faculty of Medicine and Dentistry, University of Alberta Canada.
Abdelrahman I AbdelrahmanDepartment of Diagnostic Radiology, Zagazig Faculty of Medicine, Zagazig University Egypt.
Rehab El-TahlawiDepartment of Microbiology, College of Medicine, Taibah University Saudi Arabia.
Manal Mohamed Helmy NaboDivision of Pediatric Cardiology, Pediatrics Department, Maternity and Children Hospital Hail, Saudi Arabia.
Reda S YousefDepartment of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University Egypt.
Ahmed Alamir MahmoudDepartment of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University Egypt.
Yasser Yahia ElsayedDepartment of Neonatology Maternity Hospital Kuwait, Kuait.
Mostafa Abu-ElnagaDepartment of Anatomy, College of Medicine, Al-Rayyan Medical Colleges Al-Madinah, Saudi Arabia.
Tamer M SolimanDepartment of Clinical Pathology, Faculty of Medicine, Sohag University Sohag, Egypt.
Abdelhady Ragab Abdel-GawadDepartment of Clinical Pathology, Faculty of Medicine, Sohag University Sohag, Egypt.
Momen ElshazleyDepartment of Medicine, Taibah Faculty of Medicine, Taibah University Al-Madinah Al-Munawwarah, Saudi Arabia.
Hussam BaghdadiDepartment of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University Al-Madinah Al-Munawwarah, Saudi Arabia.
Samer El-SawyDepartment of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University Egypt.
Hany Salah MahmoudCenter of Scientific Foundation for Experimental Studies and Research Ismailia, Egypt.
Mariam E El-AnziDiabetic Center in King Fahd Hospital & Sayed Al-Shohada Primary Health Care Center Al-Madinah Al-Munawwarah, Saudi Arabia.
Mansour Barakah AlharbiHead of Training and Academic Affairs and Designated Institutional Official (DIO), King Fahad Hospital, Al-Madinah and Leader of Training and Academic Affairs Taskforce Al-Madinah Al-Munawwarah, Saudi Arabia.
Sohag University · EGTaibah University · SAZagazig University · EGAcademy of Scientific Research and Technology · EGAl-Azhar University · EGIslamic University of Madinah · SAKing Fahad Hospital Jeddah · SAMaternity and Children's Hospital · SARoyal Commission Medical Center · SASobhraj Maternity Hospital · PKUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Public prophylaxis to decrease the emergence of new daily COVID-19 cases is vital. Adjuvant TaibUVID nutritional supplements are promising home-made or hospital-made supplements suggested for rapidly preventing and treating COVID-19 pandemic. We report here a 44 years old male physician who caught COVID-19 infection at hospital in Egypt with confirmed positive nasopharyngeal swab PCR. Ethical committee approval and informed patient's consent were gained before performing this study. Chest X-ray revealed increased bronchovascular markings. Close follow-up was done with no treatment given and he was sent for home isolation. Few days later, he developed progressive non-productive cough and a sense of difficult breathing with no associated fever or chest pain. An antitussive drug was given to him. The patient read about TaibUVID supplements from social media and started to feel improvement after TaibUVID inhalation therapy (using the heated solution of nigella sativa and chamomile five times a day). He also received a home-made TaibUVID nutritional supplement (nigella sativa, chamomile and natural honey) five times daily for four consecutive days. The next day, he was quite better with mild symptoms. Two days later, nasopharyngeal swab PCR was negative while other patients still had positive nasopharyngeal swabs. As few attacks of mild cough and breathing difficulty existed, he was admitted to hospital. A nasopharyngeal swab PCR was done for him again and the result was negative also. Blood gases were normal. He had lymphocytosis (possibly due to TaibUVID effects) that counteract lymphopenia seen in COVID-19 patients. Biochemical and hematological evaluation were quite normal apart from increased serum chloride and lactate dehydrogenase. There was a mild decrease in serum CO

Indexed as

chamomileCOVID-19nasopharyngeal swab PCRnatural honeynigella sativaTaibUVID

Identifiers

PMID33489449
PMCPMC7811903
OpenAlexW3122629395

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.